European court rules in favor of Abbott in Dexcom CGM patent spat
Dec 12, 2024 · Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom (Nasdaq:DXCM). Abbott and Dexcom are two leaders in the continuous glucose monitoring (CGM) space.
Embecta to lay off 118 in Massachusetts
Dec 5, 2024 · Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees.. The state received Embecta’s Worker Adjustment and Retraining Notification (WARN) submission on Nov. 26 — the same day it announced plans to discontinue its insulin patch pump program and restructure.The discontinuation of the patch pump program came not long after rumors ...
These diabetes devices are set to launch in 2024 - Drug Delivery …
Feb 27, 2024 · The Stelo glucose monitor for people with diabetes who are not taking insulin. [Image courtesy of Dexcom] The diabetes space continues to innovate, and it doesn’t look like that’s stopping any time soon, with 2024 set to be another banner year. At the end of 2023, we compiled a list of the 10 biggest diabetes technology stories of the year.Some of those stories didn’t end in 2023, though ...
The 9 largest diabetes technology companies in the world
Aug 21, 2024 · Technologies from Abbott, Dexcom, Medtronic and Insulet. These companies are the four largest diabetes technology companies in the world. [Images courtesy of the companies] Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in …
Insulet fully launches Omnipod 5 app for iPhone in U.S.
Oct 29, 2024 · The Omnipod 5 with the Dexcom G7 CGM. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced the full market release of the Omnipod 5 automated insulin delivery app for iPhone in the U.S. Acton, Massachusetts-based Insulet now offers the app for free download from the Apple App Store.
Abbott opens new FreeStyle Libre manufacturing plant in Ireland
Nov 18, 2024 · The new FreeStyle Libre manufacturing plant in Kilkenny, Ireland. [Image courtesy of Abbott] Abbott (NYSE:ABT) announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland. The site serves as a global manufacturing center of excellence for Abbott’s Diabetes Care business.
Insulet prevails in IP battle with patch pump maker EOFlow
Dec 5, 2024 · The Omnipod 5 (left) and the EOFlow EOPatch (right). [Images courtesy of the companies] Insulet (Nasdaq:PODD) announced that it successfully defended its intellectual property against EOFlow in U.S. federal court. Both companies develop automated insulin delivery systems utilizing patch pump technology.
Qnovia wins FDA IND for nicotine inhaler for smoking cessation
Oct 2, 2024 · Qnovia’s nicotine replacement therapy device. [Image courtesy of Qnovia] Qnovia announced that the FDA cleared its investigational new drug (IND) application for the RespiRx smoking cessation inhaler (QN-01). RespiRx, a drug-device combination product, offers inhalable nicotine replacement therapy (NRT) to assist in the quitting of smoking.
Embecta discontinues patch pump program, plans restructuring
Nov 26, 2024 · Embecta (Nasdaq:EMBC) announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.. Shares of EMBC ticked up 4.3% to $14.41 apiece before hours after the company announced the discontinuation as part of its fourth-quarter earnings results.
Senseonics highlights early success with Eversense 365 launch
Dec 9, 2024 · The Eversense 365 long-term implantable CGM. [Image courtesy of Senseonics/Ascensia] Senseonics (NYSE:SENS) today announced significant progress with the launch of its Eversense 365 continuous glucose monitor (CGM). In September, the company won FDA clearance for the Eversense 365 one-year implantable CGM. With the clearance, it became the world’s first 365-day CGM system.